Feifei Li
725 South Wanping Road
Xuhui, 200032, China
Xuhui, 200032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Exploring the mechanism of acupuncture for Chronic Atrophic Gastritis based on bioinformatics and network topology strategies.
Journal: Biomedical journal
Published: March 17, 2026
From traditional warming and tonifying to psychoneuroimmunology: theoretical reconstruction and clinical application of moxibustion for cancer-related fatigue.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: March 17, 2026
PD-1 blockade elicits a systemic immune response but not in the tumor of TNBC mice.
Journal: Acta biochimica et biophysica Sinica
Published: February 04, 2026
Prognosis and Immunotherapy Effect of Triple-Negative Breast Cancer by Lactylation-Related Genes and Experimental Validation.
Journal: Oncology research
Published: December 23, 2025
Unraveling the breast cancer tumor microenvironment: crucial factors influencing natural killer cell function and therapeutic strategies.
Journal: International journal of biological sciences
Published: December 14, 2024
Curcumenol inhibits malignant progression and promotes ferroptosis via the SLC7A11/NF‑κB/TGF‑β pathway in triple‑negative breast cancer.
Journal: International journal of molecular medicine
Published: December 06, 2024
Long-Term Outcomes of Traditional Chinese Medicine in the Treatment of Granulomatous Lobular Mastitis: A Two-Year Follow-Up Study on Recurrence and New Occurrence Rates with Analysis of Risk Factors.
Journal: Journal of inflammation research
Published: July 04, 2024
Integrated network pharmacology and experimental verification to explore the potential mechanism of San Ying decoction for treating triple-negative breast cancer.
Journal: Acta biochimica et biophysica Sinica
Published: March 22, 2024
Xianling Lianxia formula enhances the inhibitory effects of trastuzumab on HER2-positive breast cancer.
Journal: Acta biochimica et biophysica Sinica
Published: February 21, 2024
Xianling Lianxia formula improves the efficacy of trastuzumab by enhancing NK cell-mediated ADCC in HER2-positive BC.
Journal: Journal of pharmaceutical analysis
Published: October 12, 2023
Investigating the Immunogenic Cell Death-Dependent Subtypes and Prognostic Signature of Triple-Negative Breast Cancer.
Journal: Phenomics (Cham, Switzerland)
Published: May 06, 2023
Xianlinglianxiafang Inhibited the growth and metastasis of triple-negative breast cancer via activating PPARγ/AMPK signaling pathway.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: April 28, 2023
Last Updated: 09/26/2026